BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 12915689)

  • 21. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
    Cazabat L; Ragazzon B; Groussin L; Bertherat J
    Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A girl with Cushing's syndrome due to primary pigmented nodular adrenocortical disease].
    Bocca G; van Mil EG; Voorhoeve PG; Wijnaendts LC; Delemarre-van de Waal HA
    Ned Tijdschr Geneeskd; 2006 Oct; 150(43):2390-3. PubMed ID: 17100132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenal pathophysiology: lessons from the Carney complex.
    Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
    Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical inhibitory effect of serotonin on cortisol production from adrenocortical lesions causing Cushing's syndrome.
    Louiset E; Cartier D; Contesse V; Duparc C; Lihrmann I; Young J; Bertherat J; Reznik Y; Kuhn JM; Laquerrière A; Vaudry H; Lefebvre H
    Endocr Res; 2004 Nov; 30(4):951-4. PubMed ID: 15666851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome.
    de Groot JW; Links TP; Themmen AP; Looijenga LH; de Krijger RR; van Koetsveld PM; Hofland J; van den Berg G; Hofland LJ; Feelders RA
    Eur J Endocrinol; 2010 Aug; 163(2):293-9. PubMed ID: 20460422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cushing's syndrome due to bilateral adrenocortical adenomas with unique histological features.
    Nomura K; Saito H; Aiba M; Iihara M; Obara T; Takano K
    Endocr J; 2003 Apr; 50(2):155-62. PubMed ID: 12803235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation.
    Horvath A; Mathyakina L; Vong Q; Baxendale V; Pang AL; Chan WY; Stratakis CA
    J Clin Endocrinol Metab; 2006 Feb; 91(2):584-96. PubMed ID: 16278264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.
    Bertherat J; Contesse V; Louiset E; Barrande G; Duparc C; Groussin L; Emy P; Bertagna X; Kuhn JM; Vaudry H; Lefebvre H
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1302-10. PubMed ID: 15585558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.
    Maria AG; Tatsi C; Berthon A; Drougat L; Settas N; Hannah-Shmouni F; Bertherat J; Faucz FR; Stratakis CA
    Endocr Relat Cancer; 2020 Sep; 27(9):509-517. PubMed ID: 32638579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).
    Vezzosi D; Tenenbaum F; Cazabat L; Tissier F; Bienvenu M; Carrasco CA; Laloi-Michelin M; Barrande G; Lefebvre H; Hiéronimus S; Tabarin A; Bertagna X; Legmann P; Vantyghem MC; Bertherat J
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4332-8. PubMed ID: 26390100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol.
    Louiset E; Isvi K; Gasc JM; Duparc C; Cauliez B; Laquerrière A; Kuhn JM; Lefebvre H
    Endocr Relat Cancer; 2008 Dec; 15(4):1025-34. PubMed ID: 18708508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does somatostatin have a role in the regulation of cortisol secretion in primary pigmented nodular adrenocortical disease (ppnad)? a clinical and in vitro investigation.
    Bram Z; Xekouki P; Louiset E; Keil MF; Avgeropoulos D; Giatzakis C; Nesterova M; Sinaii N; Hofland LJ; Cherqaoui R; Lefebvre H; Stratakis CA
    J Clin Endocrinol Metab; 2014 May; 99(5):E891-901. PubMed ID: 24512486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice.
    Sahut-Barnola I; de Joussineau C; Val P; Lambert-Langlais S; Damon C; Lefrançois-Martinez AM; Pointud JC; Marceau G; Sapin V; Tissier F; Ragazzon B; Bertherat J; Kirschner LS; Stratakis CA; Martinez A
    PLoS Genet; 2010 Jun; 6(6):e1000980. PubMed ID: 20548949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
    Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
    Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test.
    Mu YM; Takayanagi R; Imasaki K; Ohe K; Ikuyama S; Yanase T; Nawata H
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):301-6. PubMed ID: 9861319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.
    Miyamura N; Taguchi T; Murata Y; Taketa K; Iwashita S; Matsumoto K; Nishikawa T; Toyonaga T; Sakakida M; Araki E
    Endocrine; 2002 Dec; 19(3):319-26. PubMed ID: 12624433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
    Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
    Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.